Net gamma exposure for Bristol-Myers Squibb Co (BMY) options was positive at the Nov 4, 2026 close, about $12.2M per 1% move in the stock. It has been positive on 13 of the last 20 trading days. With positive gamma, dealer hedging tends to lean against price moves, which can dampen swings.
Upgrade to unlock Gamma Flip, Gamma Profile, Call Wall, Put Wall, and multiple expiration dates.
Gamma Exposure by Strike
Showing results for BMY, 2026-11-06(w), calls & puts
Gamma Exposure Stats
Showing results for BMY, 2026-11-06(w), calls & puts
Net Gamma Exposure by Expiration
Showing results for BMY, 2026-11-06(w), calls & puts. View all expiries
| Expiration | Net GEX | Call GEX | Put GEX | Call Wall | Put Wall | Gamma Flip |
|---|
BMY Gamma Exposure FAQ
What is gamma exposure (GEX)?
Gamma exposure estimates how much stock option dealers must buy or sell to stay hedged for each 1% move in the underlying.
Is BMY gamma exposure positive or negative?
Bristol-Myers Squibb net gamma exposure was positive on Nov 4, 2026, at $12.2M. It has been positive on 13 of the last 20 trading days.
How has BMY gamma exposure changed recently?
Bristol-Myers Squibb net gamma exposure went from -$5.8M on Oct 7, 2026 to $12.2M on Nov 4, 2026. See the BMY gamma exposure history for a longer view.
What is Bristol-Myers Squibb Co?
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders.